EQRx, Inc.

EQRx, Inc. (Nasdaq: EQRX) is a biopharmaceutical company focused on developing and commercializing innovative medicines at significantly lower price points. The company went public through a business combination with CMLS Holdings, a special purpose acquisition company that completed its IPO in 2021 and was co-sponsored by Casdin Capital and Corvex Management. Operating in the pharmaceutical and healthcare sector, EQRx filed its 10-Q with the SEC on August 16, 2021, reflecting activity during the period leading up to the merger's close later that year. The combined company subsequently traded on Nasdaq under the EQRX ticker. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time SPAC data on EQRx and hundreds of other transactions.